Figure 2.
Figure 2. Graph demonstrating the significant difference in IUR between the low and high IC50imatinib groups. (A) For imatinib, median IUR shown in parentheses. (B) Graph demonstrating the similarity in IUR for nilotinib, between the low and high IC50nilotinib groups. Median IUR shown in parentheses. (C) Effect of the OCT-1 inhibitor prazosin on IUR for low and high IC50imatinib groups. (D) Effect of the OCT-1 inhibitor prazosin on IUR for low and high IC50niltoinib groups. Error bars indicate one standard deviation (SD).

Graph demonstrating the significant difference in IUR between the low and high IC50imatinib groups. (A) For imatinib, median IUR shown in parentheses. (B) Graph demonstrating the similarity in IUR for nilotinib, between the low and high IC50nilotinib groups. Median IUR shown in parentheses. (C) Effect of the OCT-1 inhibitor prazosin on IUR for low and high IC50imatinib groups. (D) Effect of the OCT-1 inhibitor prazosin on IUR for low and high IC50niltoinib groups. Error bars indicate one standard deviation (SD).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal